EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Neuropathology of Alzheimer's Disease

Daniel P Perl

Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · 2010-01 · 77 (1) · 32-42

DOI: 10.1002/msj.20157 ↗

At a glance

Übersichtsarbeit in Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, published online on 2010-01-25. Written by Daniel P Perl. Institution: Neuropathology Division, Mount Sinai School of Medicine, New York, NY, USA. daniel.perl@mssm.edu. Cited 697 times so far (Crossref); 61 references. The full text is freely available in PubMed Central. Funded by: NIA NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Alois Alzheimer first pointed out that the disease which would later bear his name has a distinct and recognizable neuropathological substrate. Since then, much has been added to our understanding of the pathological lesions associated with the condition. The 2 primary cardinal lesions associated with Alzheimer's disease are the neurofibrillary tangle and the senile plaque. The neurofibrillary tangle consists of abnormal accumulations of abnormally phosphorylated tau within the perikaryal cytoplasm of certain neurons. The senile plaque consists of a central core of beta‐amyloid, a 4‐kD peptide, surrounded by abnormally configured neuronal processes or neurites. Other neuropathological lesions are encountered in cases of Alzheimer's disease, but the disease is defined and recognized by these 2 cardinal lesions. Other lesions include poorly understood changes such as granulovacuolar degeneration and eosinophilic rodlike bodies (Hirano bodies). The loss of synaptic components is a change that clearly has a significant impact on cognitive function and represents another important morphological alteration. It is important to recognize that distinguishing between Alzheimer's disease, especially in its early stages, and normal aging may be very difficult, particularly if one is examining the brains of patients who died at an advanced old age. It is also noted that instances of pure forms of Alzheimer's disease, in the absence of other coexistent brain disease processes, such as infarctions or Parkinson's disease–related lesions, are relatively uncommon, and this must be taken into account by researchers who employ postmortem brain tissues for research. Mt Sinai J Med 77:32&–42, 2010. © 2010 Mount Sinai School of Medicine

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesBrainBrain DiseasesHumansNeurofibrillary TanglesPlaque, Amyloid

Substances

Amyloid beta-Peptides

Authors and institutions

  • Neuropathology Division, Mount Sinai School of Medicine, New York, NY, USA. daniel.perl@mssm.edu

Funding

  • NIA NIH HHS

Cite

APA

Perl, D. P. (2010). Neuropathology of Alzheimer's Disease. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 77(1), 32-42. https://doi.org/10.1002/msj.20157

Vancouver

Perl DP. Neuropathology of Alzheimer's Disease. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine. 2010;77(1):32-42. doi:10.1002/msj.20157

BibTeX
@article{Perl2010,
  author = {Perl, Daniel P},
  title = {Neuropathology of Alzheimer's Disease},
  journal = {Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine},
  year = {2010},
  volume = {77},
  number = {1},
  pages = {32--42},
  doi = {10.1002/msj.20157}
}
Start for free →